Chicago Partners Investment Group LLC Invests $277,000 in DENTSPLY SIRONA Inc. $XRAY

Chicago Partners Investment Group LLC acquired a new position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund acquired 16,462 shares of the medical instruments supplier’s stock, valued at approximately $277,000.

Several other large investors have also recently modified their holdings of XRAY. Public Employees Retirement System of Ohio increased its holdings in DENTSPLY SIRONA by 1.4% during the 2nd quarter. Public Employees Retirement System of Ohio now owns 61,873 shares of the medical instruments supplier’s stock valued at $983,000 after purchasing an additional 861 shares during the period. Gabelli Funds LLC increased its holdings in DENTSPLY SIRONA by 1.0% during the 1st quarter. Gabelli Funds LLC now owns 98,000 shares of the medical instruments supplier’s stock valued at $1,464,000 after purchasing an additional 1,000 shares during the period. Empowered Funds LLC increased its holdings in DENTSPLY SIRONA by 8.8% during the 1st quarter. Empowered Funds LLC now owns 16,324 shares of the medical instruments supplier’s stock valued at $244,000 after purchasing an additional 1,320 shares during the period. Covestor Ltd increased its holdings in DENTSPLY SIRONA by 17.5% during the 1st quarter. Covestor Ltd now owns 9,778 shares of the medical instruments supplier’s stock valued at $146,000 after purchasing an additional 1,456 shares during the period. Finally, Mirae Asset Global Investments Co. Ltd. purchased a new position in DENTSPLY SIRONA during the 1st quarter valued at about $25,000. Hedge funds and other institutional investors own 95.70% of the company’s stock.

DENTSPLY SIRONA Stock Performance

DENTSPLY SIRONA stock opened at $13.11 on Friday. The company has a quick ratio of 1.11, a current ratio of 1.69 and a debt-to-equity ratio of 1.13. The company has a market capitalization of $2.62 billion, a P/E ratio of -2.77, a PEG ratio of 0.83 and a beta of 0.96. The stock’s 50 day moving average is $13.35 and its 200 day moving average is $14.50. DENTSPLY SIRONA Inc. has a twelve month low of $11.69 and a twelve month high of $24.86.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its quarterly earnings results on Thursday, August 7th. The medical instruments supplier reported $0.52 earnings per share for the quarter, topping the consensus estimate of $0.50 by $0.02. The company had revenue of $936.00 million for the quarter, compared to the consensus estimate of $929.67 million. DENTSPLY SIRONA had a positive return on equity of 16.33% and a negative net margin of 25.85%.The firm’s quarterly revenue was down 4.9% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.49 EPS. DENTSPLY SIRONA has set its FY 2025 guidance at 1.800-2.000 EPS. On average, equities research analysts predict that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current fiscal year.

DENTSPLY SIRONA Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, October 10th. Investors of record on Friday, September 26th were paid a $0.16 dividend. The ex-dividend date was Friday, September 26th. This represents a $0.64 annualized dividend and a dividend yield of 4.9%. DENTSPLY SIRONA’s dividend payout ratio is presently -13.50%.

Wall Street Analyst Weigh In

XRAY has been the topic of a number of research analyst reports. Stifel Nicolaus reduced their price target on DENTSPLY SIRONA from $19.00 to $17.00 and set a “hold” rating on the stock in a report on Friday, August 8th. Needham & Company LLC reiterated a “hold” rating on shares of DENTSPLY SIRONA in a report on Friday, September 26th. Weiss Ratings restated a “sell (d-)” rating on shares of DENTSPLY SIRONA in a research note on Friday. Wall Street Zen lowered DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research report on Saturday, October 18th. Finally, Evercore ISI reduced their price target on DENTSPLY SIRONA from $17.00 to $13.00 and set an “in-line” rating on the stock in a research note on Wednesday, October 8th. Two investment analysts have rated the stock with a Buy rating, eleven have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and an average target price of $18.00.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.